article thumbnail

Script for success: The value of digital insights in pharma

BioPharma Drive: Drug Pricing

Pharma companies can thrive in 2024 by leveraging digital intelligence to anticipate trends, analyze sentiment, and engage audiences. Discover how data-driven insights drive success.

article thumbnail

5 Anticipated Ophthalmology Therapies in 2024

Vial

As we look forward to 2024, several groundbreaking therapies are poised to radically change the landscape of ophthalmology, providing hope and improved treatment options for patients with ocular conditions. The intention is to recruit 18 participants for the trial, with results expected to be announced in 2024 or 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Level Up Your Lab Data: New Use Cases for Improving Time to Treatment

Fierce BioTech

Listing Image QuartzListingLogo_250x190_norstella.png Listing Introduction Real-world data is essential to gaining insights into a patient’s diagnostic journey, but many pharma companies may not be using lab data, in particular, to its full potential. On Demand Start Date Tue, 10/29/2024 - 12:00

article thumbnail

Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

Alta Sciences

CROs have historically functioned as auxiliaries to pharma companies, conducting the work sponsors can’t do in-house. In addition to cost savings, CROs offered access to greater scientific knowledge and expertise, especially for regulatory requirements, as drug development became increasingly complex.

article thumbnail

Fierce Biotech Week

Fierce BioTech

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

article thumbnail

Streamlining Compliance: Outsourcing combined services and technology in pharmacovigilance and regulatory affairs

Fierce BioTech

Streamlining Compliance: Outsourcing combined services and technology in pharmacovigilance and regulatory affairs Biotech and pharma companies are already tapping into the benefits of outsourcing. dfarris Tue, 02/13/2024 - 12:20 Biotech and pharma companies are already tapping into the benefits of outsourcing.

article thumbnail

ACTO EXPANDS INVESTMENT IN ARTIFICIAL INTELLIGENCE TO SOLVE UNMET NEEDS IN THE LIFE SCIENCES INDUSTRY

ACTO

We believe ACTO’s early focus and deep expertise in AI, along with their demonstrated success in solving challenges faced by pharma companies, positions them to best lead the AI charge on the commercial side of life sciences.” “The For more information on the critical gap in pharma omnichannel engagement, read the eBook.

Science 52